Serum bilirubin level correlates with mortality in patients with traumatic brain injury. Issue 27 (2nd July 2020)

• Record Type: Journal Article
• Authors: Wang, Ruoran; He, Min; Xu, Jianguo
• Other Names: Schaller. Bernhard section editor.
• Is Part Of: Medicine. Volume 99:Issue 27(2020)
• Publication Date: 2020-07-02
• Subjects: bilirubin -- marker -- prognosis -- traumatic brain injury; Medicine -- Periodicals; Medicine -- Periodicals; Médecine -- Périodiques; Geneeskunde; Medicine; Periodicals; Periodicals; 610.5
• DOI: 10.1097/MD.0000000000021020
• Languages: English
• ISSNs: 0025-7974

Abstract

Abstract : Abstract: As a catabolic product of hemoglobin, bilirubin has been confirmed playing an important role in the development of various central nervous system disease. The aim of this study is to explore the correlation between serum bilirubin level and mortality in patients with traumatic brain injury (TBI). Patients admitted with traumatic brain injury (TBI) in our hospital between January 2015 and January 2018 were enrolled in this study. Clinical and laboratory data of 361 patients were retrospectively collected to explore the independent risk factors of mortality. The comparison of baseline characteristics showed that non-survivors had lower Glasgow Coma Scale (GCS) ( P < .001) and higher level of serum total bilirubin (TBIL) ( P < .001) and direct bilirubin (DBIL) ( P < .001). We found that only GCS ( P < .001), glucose ( P < .001), lactate dehydrogenase (LDH) ( P = .042) and DBIL ( P = .005) were significant risk factors in multivariate logistic regression analysis. GCS and DBIL had comparable AUC value (0.778 vs 0.750, P > .05) on predicting mortality in TBI patients. The AUC value of the combination of GCS and DBIL is higher than the single value of these two factors ( P < .05). Moreover, predictive model 1 consisted of GCS, glucose, LDH and DBIL had the highest AUC value of 0.894. DBIL is a significant risk factor of mortality in TBI patients. Assessing the level of DBIL is beneficial for physicians to evaluate severity and predict outcome for TBI patients.